Resistance

Biomarker

1 paper

  • Humans1

Latest

Nov 2025: 100Dec 2025: 172Jan 2026: 131Feb 2026: 94Mar 2026: 92Apr 2026: 114May 2026: 96Jun 2026: 179Jul 2026: 170Aug 2026: 328Sep 2026: 328Oct 2026: 1501,954 in 12 months
Research Square

Brain scan markers may track different processes after sleep loss

In a 429-person sleep intervention study, proposed brain-scan measures of waste clearance responded differently to restricted sleep and prolonged wakefulness.In a 429-person sleep intervention study, proposed brain-scan measures of waste clearance responded differently to restricted sleep and prolonged wakefulness.

Preprint: non-randomised trial in 429 people exposed to short-term sleep loss, against habitual sleepMechanisms

Limit: MRI indices were indirect markers, not direct measurements of brain waste clearance

bioRxiv

End-to-end genome map completed for the naked mole-rat

A genome-sequencing study resolved both inherited copies of the naked mole-rat genome, using gene-activity data from 23 tissues to identify its genes.A genome-sequencing study resolved both inherited copies of the naked mole-rat genome, using gene-activity data from 23 tissues to identify its genes.

Preprint: study of naked mole-ratsAI & data

Limit: Genome comparisons cannot determine gene changes’ effects on longevity or cancer resistance

Cell Death & Disease

Lowering a protein reduced drug sensitivity in senescent cells

In laboratory experiments, reducing the protein weakened two drugs’ cell-killing effects without changing the usual signs of senescence, a state in which cells stop…In laboratory experiments, reducing the protein weakened two drugs’ cell-killing effects without changing the usual signs of senescence, a state in which cells stop dividing.

Experiments in senescent cells and aged miceCellular senescence

Limit: Drug doses were not reported, limiting interpretation of the reduced drug sensitivity

Journal of the American Heart Association

Dapagliflozin may help frail patients more after valve replacement

In frail patients, dapagliflozin was linked to lower relative risk of death or worsening heart failure versus controls at one year (hazard ratio 0.53).In frail patients, dapagliflozin was linked to lower relative risk of death or worsening heart failure versus controls at one year (hazard ratio 0.53).

Study of 1,222 patients undergoing transcatheter aortic valve implantation, against frail controlsDapagliflozin

Limit: Frailty subgroups were analysed after the fact, so the apparent extra benefit needs confirmation